| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 758505
[patent_doc_number] => 07015315
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-03-21
[patent_title] => 'Gapped oligonucleotides'
[patent_app_type] => utility
[patent_app_number] => 08/465866
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 16135
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/015/07015315.pdf
[firstpage_image] =>[orig_patent_app_number] => 08465866
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/465866 | Gapped oligonucleotides | Jun 5, 1995 | Issued |
| 08/465932 | ANAEROBE TARGETED ENZYME-MEDIATED PRODRUG THERAPY | Jun 5, 1995 | Abandoned |
| 08/466370 | ORGAN FUNCTION REPLACEMENT COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | Jun 5, 1995 | Abandoned |
Array
(
[id] => 3758803
[patent_doc_number] => 05843761
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-01
[patent_title] => 'CDNA coding for carcinoembryonic antigen'
[patent_app_type] => 1
[patent_app_number] => 8/469987
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 10897
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/843/05843761.pdf
[firstpage_image] =>[orig_patent_app_number] => 469987
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/469987 | CDNA coding for carcinoembryonic antigen | Jun 5, 1995 | Issued |
Array
(
[id] => 3951967
[patent_doc_number] => 05955589
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-21
[patent_title] => 'Gapped 2\' modified oligonucleotides'
[patent_app_type] => 1
[patent_app_number] => 8/465880
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 17361
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/955/05955589.pdf
[firstpage_image] =>[orig_patent_app_number] => 465880
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/465880 | Gapped 2' modified oligonucleotides | Jun 5, 1995 | Issued |
| 08/468407 | METHOD FOR PROLONGING THE EXPRESSION OF A GENE OF INTEREST USING SOLUBLE CTLA4 MOLECULES | Jun 4, 1995 | Abandoned |
Array
(
[id] => 3768334
[patent_doc_number] => 05849586
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-15
[patent_title] => 'Infective protein delivery system'
[patent_app_type] => 1
[patent_app_number] => 8/464315
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 15
[patent_no_of_words] => 17819
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/849/05849586.pdf
[firstpage_image] =>[orig_patent_app_number] => 464315
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/464315 | Infective protein delivery system | Jun 4, 1995 | Issued |
Array
(
[id] => 4074507
[patent_doc_number] => 06069296
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-30
[patent_title] => 'Regulators of G-protein signalling'
[patent_app_type] => 1
[patent_app_number] => 8/460505
[patent_app_country] => US
[patent_app_date] => 1995-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 16731
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/069/06069296.pdf
[firstpage_image] =>[orig_patent_app_number] => 460505
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/460505 | Regulators of G-protein signalling | Jun 1, 1995 | Issued |
Array
(
[id] => 3859744
[patent_doc_number] => 05795745
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-08-18
[patent_title] => 'Human growth hormone'
[patent_app_type] => 1
[patent_app_number] => 8/457282
[patent_app_country] => US
[patent_app_date] => 1995-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6266
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 266
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/795/05795745.pdf
[firstpage_image] =>[orig_patent_app_number] => 457282
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/457282 | Human growth hormone | May 31, 1995 | Issued |
Array
(
[id] => 3943426
[patent_doc_number] => 05955056
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-21
[patent_title] => 'Mutagenesis testing using transgenic non-human animals carrying test DNA sequences'
[patent_app_type] => 1
[patent_app_number] => 8/397504
[patent_app_country] => US
[patent_app_date] => 1995-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 22586
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/955/05955056.pdf
[firstpage_image] =>[orig_patent_app_number] => 397504
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/397504 | Mutagenesis testing using transgenic non-human animals carrying test DNA sequences | May 30, 1995 | Issued |
| 08/455647 | COSMETIC COMPOSITIONS INCLUDING TROPOELASTIN ISOMORPHS | May 30, 1995 | Abandoned |
Array
(
[id] => 3621609
[patent_doc_number] => 05602006
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-02-11
[patent_title] => 'Heteropolymeric protein production methods'
[patent_app_type] => 1
[patent_app_number] => 8/455396
[patent_app_country] => US
[patent_app_date] => 1995-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 5564
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 211
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/602/05602006.pdf
[firstpage_image] =>[orig_patent_app_number] => 455396
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/455396 | Heteropolymeric protein production methods | May 30, 1995 | Issued |
Array
(
[id] => 3655693
[patent_doc_number] => 05658760
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-08-19
[patent_title] => 'Heteropolymeric protein production methods'
[patent_app_type] => 1
[patent_app_number] => 8/455394
[patent_app_country] => US
[patent_app_date] => 1995-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 5668
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 209
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/658/05658760.pdf
[firstpage_image] =>[orig_patent_app_number] => 455394
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/455394 | Heteropolymeric protein production methods | May 30, 1995 | Issued |
Array
(
[id] => 1544776
[patent_doc_number] => 06444438
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-03
[patent_title] => 'Method for the preparation of a protein by yeasts using an inducible system, vectors and correspondence transformed strains'
[patent_app_type] => B1
[patent_app_number] => 08/453998
[patent_app_country] => US
[patent_app_date] => 1995-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 10127
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 255
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/444/06444438.pdf
[firstpage_image] =>[orig_patent_app_number] => 08453998
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/453998 | Method for the preparation of a protein by yeasts using an inducible system, vectors and correspondence transformed strains | May 29, 1995 | Issued |
Array
(
[id] => 4188660
[patent_doc_number] => 06093802
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-25
[patent_title] => 'Glial cell line-derived neurotrophic factor'
[patent_app_type] => 1
[patent_app_number] => 8/451374
[patent_app_country] => US
[patent_app_date] => 1995-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 37
[patent_no_of_words] => 30725
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/093/06093802.pdf
[firstpage_image] =>[orig_patent_app_number] => 451374
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/451374 | Glial cell line-derived neurotrophic factor | May 25, 1995 | Issued |
Array
(
[id] => 3532545
[patent_doc_number] => 05556782
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-09-17
[patent_title] => 'Transformed mammalian cells capable of expressing cecropin b'
[patent_app_type] => 1
[patent_app_number] => 8/450252
[patent_app_country] => US
[patent_app_date] => 1995-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6735
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/556/05556782.pdf
[firstpage_image] =>[orig_patent_app_number] => 450252
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/450252 | Transformed mammalian cells capable of expressing cecropin b | May 24, 1995 | Issued |
Array
(
[id] => 4056532
[patent_doc_number] => 05863797
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-26
[patent_title] => 'Gene fusion encoding a hypersecretor protein'
[patent_app_type] => 1
[patent_app_number] => 8/448897
[patent_app_country] => US
[patent_app_date] => 1995-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 15
[patent_no_of_words] => 17811
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/863/05863797.pdf
[firstpage_image] =>[orig_patent_app_number] => 448897
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/448897 | Gene fusion encoding a hypersecretor protein | May 23, 1995 | Issued |
| 08/441941 | OLIGONUCLEOTIDES WITH ACTIVITY AGAINST HUMAN IMMUNODEFICIENCY VIRUS | May 15, 1995 | Abandoned |
Array
(
[id] => 3585712
[patent_doc_number] => 05552314
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-09-03
[patent_title] => 'Cloning host organisms'
[patent_app_type] => 1
[patent_app_number] => 8/441368
[patent_app_country] => US
[patent_app_date] => 1995-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 4933
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/552/05552314.pdf
[firstpage_image] =>[orig_patent_app_number] => 441368
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/441368 | Cloning host organisms | May 14, 1995 | Issued |
Array
(
[id] => 3661328
[patent_doc_number] => 05656596
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-08-12
[patent_title] => 'Method of treating lesions in a nervous system'
[patent_app_type] => 1
[patent_app_number] => 8/439704
[patent_app_country] => US
[patent_app_date] => 1995-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 14920
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/656/05656596.pdf
[firstpage_image] =>[orig_patent_app_number] => 439704
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/439704 | Method of treating lesions in a nervous system | May 11, 1995 | Issued |